C07D 241/14
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D241/14 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 1,727 US grants and 1,806 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,727
- Published applications
- 1,806
- Assignees
- 759
- Inventors
- 5,701
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 9 | 0 |
| 1978 | 15 | 0 |
| 1979 | 14 | 0 |
| 1980 | 12 | 0 |
| 1981 | 11 | 0 |
| 1982 | 9 | 0 |
| 1983 | 7 | 0 |
| 1984 | 14 | 0 |
| 1985 | 21 | 0 |
| 1986 | 19 | 0 |
| 1987 | 22 | 0 |
| 1988 | 19 | 0 |
| 1989 | 28 | 0 |
| 1990 | 30 | 0 |
| 1991 | 20 | 0 |
| 1992 | 20 | 0 |
| 1993 | 14 | 0 |
| 1994 | 17 | 0 |
| 1995 | 18 | 0 |
| 1996 | 18 | 0 |
| 1997 | 23 | 0 |
| 1998 | 21 | 0 |
| 1999 | 37 | 0 |
| 2000 | 29 | 0 |
| 2001 | 41 | 7 |
| 2002 | 32 | 44 |
| 2003 | 32 | 76 |
| 2004 | 33 | 82 |
| 2005 | 35 | 71 |
| 2006 | 39 | 58 |
| 2007 | 45 | 63 |
| 2008 | 38 | 63 |
| 2009 | 30 | 79 |
| 2010 | 47 | 90 |
| 2011 | 50 | 74 |
| 2012 | 70 | 77 |
| 2013 | 57 | 75 |
| 2014 | 82 | 95 |
| 2015 | 85 | 105 |
| 2016 | 63 | 70 |
| 2017 | 72 | 91 |
| 2018 | 68 | 78 |
| 2019 | 70 | 80 |
| 2020 | 59 | 73 |
| 2021 | 40 | 63 |
| 2022 | 38 | 65 |
| 2023 | 35 | 72 |
| 2024 | 32 | 67 |
| 2025 | 42 | 54 |
| 2026 | 31 | 34 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Method for preparing 3,6-diaminopyrazine-2,5-dicarboxylic acid and synthetic intermediate thereof28 Jul 2026US 12,692,240 B2MediBeacon Inc.
- Aptamer nucleic acid molecule, and complex and application thereof23 Jun 2026US 12,662,676 B2East China University of Science and Technology
- Phenazine-based compounds16 Jun 2026US 12,655,111 B2CMBlu Energy AG
- Pyrazinecarboxamide analog compounds for use in treating cancer16 Jun 2026US 12,655,131 B2
- Pyrazinecarboxamide analog compounds for use in treating cancer1 Oct 2026US 2026/0297064 A1Novapano LLC
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Phenolic compounds blocking nav 1.7 and/or nav 1.8, processes for the preparation thereof, compositions, uses, methods of treatment using same and kits17 Sep 2026US 2026/0274804 A1Eurofarma Laboratorios SA
- Compound serving as ddr1 kinase inhibitor, and medicine20 Aug 2026US 2026/0242343 A1Nippon Shinyaku Co., Ltd.
- At2 antagonists for non-addictive pain relief20 Aug 2026US 2026/0242357 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- N-indanyl carboxamide derivative and agricultural/horticultural fungicide containing the derivative as active ingredient141US 4,914,097 AMitsubishi Kasei Corporation · 1990
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998
- Cell differentiation inducer110US 6,174,905 B1Mitsui Chemicals, Inc. · 2001
- Insecticidal N'-substituted-N,N'-disubstitutedhydrazines107US 6,013,836 ARohm and Haas Company · 2000
- Heteroaryl derivatives as CFTR modulators94US 8,299,099 B2Vertex Pharmaceuticals Incorporated · 2012